FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Amerisource Health Services chlorproMAZINE Hydrochloride Tablets Recall

chlorproMAZINE Hydrochloride Tablets, USP, 25 mg, packaged as a) 50 (5x10) blisterpacks

Amerisource Health Services LLC · Columbus, OH

Risk level
Class II
Reported by FDA
Sep 24, 2025
Recall ID
D-0647-2025
Check your lot numberHow we source this data

Summary

Amerisource Health Services recalled chlorproMAZINE Hydrochloride Tablets starting Aug 27, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0647-2025 on Sep 24, 2025. Reason: Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets. Status: Ongoing.

Why it was recalled

Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

Product description

chlorproMAZINE Hydrochloride Tablets, USP, 25 mg, packaged as a) 50 (5x10) blisterpacks, NDC: 60687-430-65; (Individual Dose NDC: 60687-430-11); b) 100 (10x10) blisterpacks, NDC: 60687-430-01, (Individual Dose NDC: 60687-430-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217.

Lot numbers, UPCs & expiration codes

Lot: a)1020919, 1021133, Exp 09/30/2026; 1021447, Exp 10/31/2026; 1021741, 1022202, Exp 11/30/2026; 1022474, Exp 12/31/2026 Lot: b) 1020460, exp 08/31/2026; 1022417, exp 12/31/2026

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0647-2025
Classification
Class II
Status
Ongoing
Recall initiated
Aug 27, 2025
FDA report date
Sep 24, 2025
Quantity
2,708 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Amerisource Health Services LLC

Original FDA data

Every field from FDA enforcement report D-0647-2025, exactly as published.

Show all FDA fields
City
Columbus
State
OH
Status
Ongoing
Country
United States
Event ID
97533
Address
2550 John Glenn Ave Ste A
Code information
Lot: a)1020919, 1021133, Exp 09/30/2026; 1021447, Exp 10/31/2026; 1021741, 1022202, Exp 11/30/2026; 1022474, Exp 12/31/2026 Lot: b) 1020460, exp 08/31/2026; 1022417, exp 12/31/2026
Postal code
43217-1188
Report date
Sep 24, 2025
Product type
Drugs
Recall number
D-0647-2025
Classification
Class II
Recalling firm
Amerisource Health Services LLC
Product quantity
2,708 cartons
Reason for recall
Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets.
Voluntary / mandated
Voluntary: Firm initiated
Product description
chlorproMAZINE Hydrochloride Tablets, USP, 25 mg, packaged as a) 50 (5x10) blisterpacks, NDC: 60687-430-65; (Individual Dose NDC: 60687-430-11); b) 100 (10x10) blisterpacks, NDC: 60687-430-01, (Individual Dose NDC: 60687-430-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217.
Distribution pattern
Nationwide in the USA
Recall initiation date
Aug 27, 2025
Initial firm notification
Letter
Center classification date
Sep 15, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0647-2025, published Sep 24, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls